Table 1

Characteristics of the study population and comparison between ADE and no ADE groups

Study population (n=423)ADE group (n=95)No ADE group (n=328)p Value
Female sex, n (%)210 (49.7)44 (46.3)166 (50.6)0.46
Age in years, mean (SD)62.4 (±22.2)67.4 (±21.8)61.0 (±22.2)0.013
Triage acuity score*, median (minimum–maximum)2 (1–4)2 (1–3)2 (1–4)0.58
Final ED diagnosis, n (%)
 Polypathology36 (8.5)15 (15.8)21 (6.4)0.0039
 Involuntary intoxications12 (2.8)6 (6.3)6 (1.8)0.020
 Endocrine and metabolic diseases14 (3.3)8 (8.4)6 (1.8)0.0016
 Other diagnosis classes361 (85.4)66 (69.5)295 (90.0)
ED outcome, n (%)
 Discharge165 (39.0)25 (26.3)140 (42.7)0.0040
 Hospitalisation258 (61.0)70 (73.7)188 (57.3)
 Death000
Number of daily medications, mean (SD)4.7 (±3.7)6.0 (±3.6)4.3 (±3.6)0.0025
ATC category of daily medications, n (%)
 ATM drugs (ATC A)193 (45.6)54 (56.8)139 (42.4)0.0013
 Blood and blood forming organs (ATC B)133 (31.4)36 (37.9)97 (29.6)0.13
 Cardiovascular drugs (ATC C)233 (55.1)69 (72.6)164 (50.0)<0.0001
 Musculo-skeletal drugs (ATC M)71 (16.8)21 (22.1)50 (15.2)0.11
 Nervous system drugs (ATC N)218 (51.5)58 (61.1)160 (48.8)0.0035
Self-medication, n (%)
 Yes72 (17.0)14 (14.7)58 (17.7)0.63
 No254 (60.1)61 (64.2)193 (58.8)
 Unknown97 (22.9)20 (21.1)77 (23.5)
  • * Our ED triage acuity score includes four stages of increasing priority: (1) life-threatening situation; (2) situation with no life-threat but rapid care is needed; (3) situation within emergency ability but care can be delayed; (4) situation not within emergency ability but within ambulatory setting ability. Data were missing for 15 patients.

  • ADE, adverse drug event; ATC, Anatomical Therapeutic Chemical; ATM, alimentary tract or metabolism; ED, emergency department.